[HTML][HTML] A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants

…, KP Hwang, HK Kuo, WJ Peng… - The Journal of …, 2022 - Am Soc Clin Investig
Background The Delta and Omicron variants of SARS-CoV-2 are currently responsible for
breakthrough infections due to waning immunity. We report phase I/II trial results of UB-612, a …

[HTML][HTML] UB-311, a novel UBITh® amyloid β peptide vaccine for mild Alzheimer's disease

…, K Zhao, CH Hung, Y Tseng, WJ Peng… - Alzheimer's & Dementia …, 2017 - Elsevier
Introduction A novel amyloid β (Aβ) synthetic peptide vaccine (UB-311) has been evaluated
in a first-in-human trial with patients of mild-to-moderate Alzheimer's disease. We describe …

A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

S Wang, CY Wang, HK Kuo, WJ Peng… - Emerging Microbes & …, 2022 - Taylor & Francis
The development of safe and effective vaccines to respond to COVID-19 pandemic/endemic
remains a priority. We developed a novel subunit protein-peptide COVID-19 vaccine …

[HTML][HTML] Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses

CY Wang, WJ Peng, BS Kuo, YH Ho, MS Wang… - PLoS …, 2023 - journals.plos.org
Background The SARS-CoV-2 non-Spike (S) structural protein targets on nucleocapsid (N),
membrane (M) and envelope (E), critical in the host cell interferon response and memory T-…

High neutralizing antibody levels against severe acute respiratory syndrome coronavirus 2 omicron BA. 1 and BA. 2 after UB-612 vaccine booster

…, S Wang, CY Wang, HK Kuo, WJ Peng… - The Journal of …, 2022 - academic.oup.com
The highly transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron variant has caused high rates of breakthrough infections in those previously …

[PDF][PDF] UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease

…, YH Ho, YH Pan, YT Yang, HC Chang, LF Fu, WJ Peng - Iscience, 2024 - cell.com
UB-612 pan-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine targets
the monomeric Spike S1-receptor binding domain (RBD) subunit protein along with five …

UB-612, a multitope universal vaccine eliciting a balanced B and T cell immunity against SARS-COV-2 variants of concern

…, MS Wang, YT Yang, PY Chang, YH Shen, WJ Peng - medRxiv, 2022 - medrxiv.org
Importance The SARS-CoV-2 non-spike structural proteins of nucleocapsid (N), membrane (M)
and envelope (E) are critical in the host cell interferon response and memory T-cell …

Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine

…, YH Ho, YH Pan, YT Yang, HC Chang, LF Fu, WJ Peng - medRxiv, 2023 - medrxiv.org
Background Most of current approved vaccines, based on a Spike-only as single immunogen,
fall short of producing a full-blown T-cell immunity. SARS-CoV-2 continues to evolve with …

Target integration by a chimeric Sp1 zinc finger domain-Moloney murine leukemia virus integrase in vivo

WJ Peng, CM Chang, TH Lin - Journal of biomedical science, 2002 - Springer
A specificity protein 1 (Sp1) zinc finger domain containing two tandem zinc fingers was
fused to the C terminus of the integrase (IN) protein of the Moloney murine leukemia virus (MuLV)…

UB-612 multitope vaccine targeting SARS-CoV-2 spike and non-spike proteins provides broad and durable immune responses

CY Wang, WJ Peng, BS Kuo, H Liu, YH Ho, MS Wang… - medRxiv, 2022 - medrxiv.org
The SARS-CoV-2 non-Spike (S) structural protein targets of nucleocapsid (N), membrane (M)
and envelope (E), critical in the host cell interferon response and memory T-cell immunity, …